drugset / Trial / NCT00913432
Masitinib in Combination With Methotrexate, in Treatment of Patients With Active Rheumatoid Arthritis
RandomizedParallel-groupOpen-labelTreatment
Summary
A 12-week with possible extension, phase II study to compare efficacy and safety of masitinib at 3 and 6 mg/kg/day in combination with methotrexate, in treatment of patients with active rheumatoid arthritis refractory to standard treatments.
Timeline
- Start
- 2007-03
- Primary completion
- 2009-06
- Completion
- 2010-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Masitinib | Small molecule | 3 mg/kg | Oral |
| Subject | Masitinib | Small molecule | 6 mg/kg | Oral |